Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001415889-23-008293

EVP, CHIEF FINANCIAL OFFICER acquired 77,900 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lucera Erick EVP, CHIEF FINANCIAL OFFICER 2023-05-17 Grant or award +77,900 77,900 D
Derivatives
Lucera Erick EVP, CHIEF FINANCIAL OFFICER 2023-05-17 Grant or award · Stock Option (right to buy) +155,800 155,800 D
Loading xslF345X04/form4-05182023_090554.xml…